CAS RN: 159303-54-5
METHYL (3S,6S,8AS)-6-[(TERT-BUTOXYCARBONYL)AMINO]-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250504
100mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 159303-54-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shanghai
Inquiry
159303-54-5 / methyl (3S,6S,8aS)-6-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carboxylate
Standard CAS: 159303-54-5
Multi CAS: No
Basic Information
copy
CAS
159303-54-5 copy
Multi CAS
No copy
Molecular Formula
C15H24N2O5 copy
Molecular Weight
312.360000 copy
Exact Mass
312.168522 copy
SMILES
CC(C)(C)OC(=O)N[C@H]1CC[C@H]2CC[C@H](N2C1=O)C(=O)OC copy
InChI
InChI=1S/C15H24N2O5/c1-15(2,3)22-14(20)16-10-7-5-9-6-8-11(13(19)21-4)17(9)12(10)18/h9-11H,5-8H2,1-4H3,(H,16,20)/t9-,10-,11-/m0/s1 copy
InChIKey
RBDIIUAKDGDILT-DCAQKATOSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
22 copy
Fraction Csp3
0.8 copy
Rotatable bonds
2 copy
H-bond acceptors
5 copy
H-bond donors
1 copy
Molar refractivity
78.06 copy
TPSA
84.94 copy
LogP / Solubility
WLOGP
1.21 copy
MLOGP
1.07 copy
XLogP3
1.5 copy
Consensus LogP
1.26 copy
Log S (ESOL)
-2.4 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.99 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.93 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.77 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
4 copy